Literature DB >> 2952015

Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.

R J Falk, E Podack, A P Dalmasso, J C Jennette.   

Abstract

The S protein (S) binds to the attack complex of complement (C5b-9) in plasma preventing cytolysis. Using immunofluorescence microscopy, the authors determined the distribution of S in human renal tissue and its relationship to C5b-9, immunoglobulins, C3, albumin, and fibronectin. They examined normal and diseased human kidney tissue from patients with several forms of glomerulonephritis, diabetic nephropathy, and arterionephrosclerosis. S and C5b-9 were found in all diseased tissues; their amounts and distribution directly correlated with severity and location of injury. S and C5b-9 were colocalized in all immune deposits and in all injured glomeruli, tubular basement membranes, and vessel walls. Other than within immune deposits, S and C5b-9 were usually not colocalized with C3. This study demonstrates that S is deposited in areas of tissue injury and thus may participate in the pathogenesis of renal damage. Because in tissue S and C5b-9 are always associated, the attack complex in tissue must either be derived from the circulation as SC5b-9 or it must be capable of binding S after the formation in situ of C5b-9.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952015      PMCID: PMC1899591     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

Review 1.  Membrane attack complex of complement as a pathologic mediator.

Authors:  G Biesecker
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

2.  Monoclonal antibodies to human renal basement membranes: heterogenic and ontogenic changes.

Authors:  A F Michael; J Y Yang; R J Falk; M J Bennington; J I Scheinman; R L Vernier; A J Fish
Journal:  Kidney Int       Date:  1983-07       Impact factor: 10.612

3.  Neoantigens of the membrane attack complex of human complement.

Authors:  W P Kolb; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

4.  Selective binding of IgG4 and other negatively charged plasma proteins in normal and diabetic human kidneys.

Authors:  T Melvin; Y Kim; A F Michael
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

5.  Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis.

Authors:  G C Groggel; D J Salant; C Darby; H G Rennke; W G Couser
Journal:  Kidney Int       Date:  1985-04       Impact factor: 10.612

6.  Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus.

Authors:  R J Falk; A P Dalmasso; Y Kim; S Lam; A Michael
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

7.  Serum spreading factor (vitronectin) is present at the cell surface and in tissues.

Authors:  E G Hayman; M D Pierschbacher; Y Ohgren; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.

Authors:  G C Groggel; S Adler; H G Rennke; W G Couser; D J Salant
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

9.  Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.

Authors:  R J Falk; A P Dalmasso; Y Kim; C H Tsai; J I Scheinman; H Gewurz; A F Michael
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  Interaction of antigen load and antibody response in determining heterologous protein nephritogenicity in inbred mice.

Authors:  S S Iskandar; J C Jennette
Journal:  Lab Invest       Date:  1983-06       Impact factor: 5.662

View more
  26 in total

1.  Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.

Authors:  G Triolo; E Giardina; D Casiglia; G Scarantino; G D Bompiani
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

2.  S protein binds to serum-treated agarose beads independently of complement activation and the formation of the terminal complement complex on the beads.

Authors:  G Hetland; P Garred; H B Pettersen; T E Mollnes; E Johnson
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 3.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

4.  Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.

Authors:  S Bhakdi; R Käflein; T S Halstensen; F Hugo; K T Preissner; T E Mollnes
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

5.  Terminal complement complex (TCC) and S-protein (vitronectin) on follicular dendritic cells in human lymphoid tissues.

Authors:  T S Halstensen; T E Mollnes; P Brandtzaeg
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

6.  Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.

Authors:  T S Halstensen; T E Mollnes; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

7.  Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae.

Authors:  F Tedesco; O Radillo; G Candussi; A Nazzaro; T E Mollnes; D Pecorari
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

8.  Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.

Authors:  M Okada; K Yoshioka; T Takemura; N Akano; N Aya; K Murakami; S Maki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  The kinetics and distribution of C9 and SC5b-9 in vivo: effects of complement activation.

Authors:  J D Greenstein; P W Peake; J A Charlesworth
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

10.  Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).

Authors:  J H Jansen; K Høgåsen; T E Mollnes
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.